Wang D - Search Results

1

Efficacy of intracellular immune checkpoint-silenced DC vaccine.

Wang D, Huang XF, Hong B, Song XT, Hu L, Jiang M, Zhang B, Ning H, Li Y, Xu C, Lou X, Li B, Yu Z, Hu J, Chen J, Yang F, Gao H, Ding G, Liao L, Rollins L, Jones L, Chen SY, Chen H. Wang D, et al. JCI Insight. 2018 Feb 8;3(3):e98368. doi: 10.1172/jci.insight.98368. eCollection 2018 Feb 8. JCI Insight. 2018. PMID: 29415891 Free PMC article. Clinical Trial.

2

Outcome of myeloablative allogeneic peripheral blood hematopoietic stem cell transplantation for refractory/relapsed AML patients in NR status.

Liu N, Ning HM, Hu LD, Jiang M, Xu C, Hu JW, Wang J, Li YH, Li BT, Lou X, Yang F, Chen JL, Su YF, Li M, Wang HY, Ren J, Feng YQ, Zhang B, Wang DH, Chen H. Liu N, et al. Leuk Res. 2015 Dec;39(12):1375-81. doi: 10.1016/j.leukres.2015.10.011. Epub 2015 Oct 19. Leuk Res. 2015. PMID: 26530539

3

Adoptive cellular immunotherapy in metastatic renal cell carcinoma: a systematic review and meta-analysis.

Tang X, Liu T, Zang X, Liu H, Wang D, Chen H, Zhang B. Tang X, et al. Among authors: wang d. PLoS One. 2013 May 7;8(5):e62847. doi: 10.1371/journal.pone.0062847. Print 2013. PLoS One. 2013. PMID: 23667530 Free PMC article. Review.

4

Clinical research of genetically modified dendritic cells in combination with cytokine-induced killer cell treatment in advanced renal cancer.

Wang D, Zhang B, Gao H, Ding G, Wu Q, Zhang J, Liao L, Chen H. Wang D, et al. BMC Cancer. 2014 Apr 10;14:251. doi: 10.1186/1471-2407-14-251. BMC Cancer. 2014. PMID: 24720900 Free PMC article. Clinical Trial.

5

Identification of a novel functional JAK1 S646P mutation in acute lymphoblastic leukemia.

Li Q, Li B, Hu L, Ning H, Jiang M, Wang D, Liu T, Zhang B, Chen H. Li Q, et al. Among authors: wang d. Oncotarget. 2017 May 23;8(21):34687-34697. doi: 10.18632/oncotarget.16670. Oncotarget. 2017. PMID: 28410228 Free PMC article.

6

Treatment of Psoriasis with Mesenchymal Stem Cells.

Chen H, Niu JW, Ning HM, Pan X, Li XB, Li Y, Wang DH, Hu LD, Sheng HX, Xu M, Zhang L, Zhang B. Chen H, et al. Am J Med. 2016 Mar;129(3):e13-4. doi: 10.1016/j.amjmed.2015.11.001. Epub 2015 Nov 12. Am J Med. 2016. PMID: 26582058 No abstract available.

7

Third-generation CD28/4-1BB chimeric antigen receptor T cells for chemotherapy relapsed or refractory acute lymphoblastic leukaemia: a non-randomised, open-label phase I trial protocol.

Tang XY, Sun Y, Zhang A, Hu GL, Cao W, Wang DH, Zhang B, Chen H. Tang XY, et al. BMJ Open. 2016 Dec 30;6(12):e013904. doi: 10.1136/bmjopen-2016-013904. BMJ Open. 2016. PMID: 28039295 Free PMC article. Clinical Trial.

8

[The clinical research of nonmyeloablative allogeneic peripheral blood hematopoietic stem cells transplantation for hematological diseases].

Ai HS, Yu CL, Wang DH, Guo M, Qiao JH, Shi BF, Sun WJ, Zhang S, Sun QY, Yao B. Ai HS, et al. Zhonghua Xue Ye Xue Za Zhi. 2003 Feb;24(2):86-9. Zhonghua Xue Ye Xue Za Zhi. 2003. PMID: 12697103 Chinese.

9

[Changes of lymphocyte subsets in acute leukemia patients after HLA-mismatched nonmyeloablative hematopoietic stem cell transplantation].

Hu KX, Guo M, Yu CL, Wang DH, Sun QY, Qiao JH, Liu GX, Liu TQ, Ai HS. Hu KX, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009 Dec;17(6):1527-31. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009. PMID: 20030940 Chinese.

10

[Relationship between WT1-specific T-cell subsets and graft-versus-host disease after nonmyeloablative allogeneic transplantation].

Wei L, Zuo HL, Liu TQ, Sun XD, Guo M, Liu GX, Sun QY, Qiao JH, Wang DH, Yu CL, Hu KX, Dong Z, Ai HS. Wei L, et al. Zhonghua Xue Ye Xue Za Zhi. 2011 Feb;32(2):89-93. Zhonghua Xue Ye Xue Za Zhi. 2011. PMID: 21429373 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

58,266 results

Search Page